This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Proteomics Industry

NEW YORK, Dec. 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Proteomics Industry

http://www.reportlinker.com/p092466/Global-Proteomics-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

 

This report analyzes the worldwide markets for Proteomics in US$ Million by the following Product Segments: Expression Proteomics, Functional Proteomics, and Structural Proteomics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period of 2010 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 111 companies including many key and niche players such as ActivX Biosciences, Inc., Adnexus Therapeutics, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Daltonics, Inc., Caprion Proteomics, Inc., Digilab Genomic Solutions, Inc., Dionex Corporation, GE Healthcare, Geneva Bioinformatics S.A., Hybrigenics SA, Life Technologies Corporation, Millipore Corp., PerkinElmer, Inc., Caliper Life Sciences, Shimadzu Biotech, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Waters Corp., Xencor Inc., and Zyomyx, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

 

 

 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Expression Proteomics I-3

Functional Proteomics I-3

Structural Proteomics I-4

 

 

II. EXECUTIVE SUMMARY

 

1. GLOBAL MARKET OVERVIEW II-1

Proteomics - The Current Spotlight II-1

Market Drivers II-1

Transition from Genomics to Proteomics II-1

Industrialization of Proteomics Research II-2

International Initiatives Light-up Proteomics Market II-2

Factors Limiting Market Growth II-2

Economic Recession Impact on the Life Sciences Industry in

Retrospect II-2

Biotechnology Sector - Affected by Collapse of Capital Market II-3

1 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 +1.21 0.06%
NASDAQ 4,828.3250 +15.6170 0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs